Viewing data from:

PYRAZINAMIDE

ANDA

PYRAZINAMIDE | A081319 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$1.45

per ea

Lowest NADAC/Unit

$1.45

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00054081221PYRAZINAMIDE 500 MG TABLET	$1.45	EA	Generic	—	2026-06-17
00054081222PYRAZINAMIDE 500 MG TABLET	$1.45	EA	Generic	—	2026-06-17
00054081225PYRAZINAMIDE 500 MG TABLET	$1.45	EA	Generic	—	2026-06-17
00054081229PYRAZINAMIDE 500 MG TABLET	$1.45	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$209.08

Highest Price

$339.66

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00054-0812-21PYRAZINAMIDE 500MG TAB	$209.08	FSS	Golden State Medical Supply, Inc.	06/14/2028
00054-0812-22PYRAZINAMIDE 500MG TAB	$311.72	FSS	Golden State Medical Supply, Inc.	06/14/2028
00054-0812-25PYRAZINAMIDE 500MG TAB	$339.66	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

DELMAR CHEMICALS INCPYRAZINAMIDE

DMF 153252001

CALYX CHEMICALS AND PHARMACEUTICALS LTDPYRAZINAMIDE USP

DMF 155532001

MACLEODS PHARMACEUTICALS LTDPYRAZINAMIDE

DMF 304482016

MATRIX PHARMACORP PRIVATE LTDPYRAZINAMIDE USP

DMF 342292019

BRACCO IND CHIMICA SPAInactivePYRAZINAMIDE

DMF 59091985

NORISTON LTDInactivePYRAZINAMIDE

DMF 86041990

SANOFI AVENTISInactivePYRAZINAMIDE

DMF 146231999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 30, 1992

No patent or exclusivity listings for this strength.